Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Carilex MedicalROCO:7726 33 5-Year Yield-on-Cost % is 1.77 as of Aug. 17, 2026, which is 57% below its 10-year median of 4.13. GuruFocus rates ROCO:7726 with a GF Score™ of 33/100. The stock has 5 warning signs investors should review. Among 317 Medical Devices & Instruments companies, Carilex Medical ranks worse than 57.73% on this metric.
Carilex Medical's yield on cost for the quarter that ended in Dec. 2025 was 1.77.
The historical rank and industry rank for Carilex Medical's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:7726'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.39 Med: 4.13 Max: 5.15
Current: 1.77
During the past 6 years, Carilex Medical's highest Yield on Cost was 5.15. The lowest was 1.39. And the median was 4.13.
ROCO:7726's 5-Year Yield-on-Cost % is ranked worse than 57.73% of 317
companies
in the Medical Devices & Instruments industry
Industry Median: 2.29
vs ROCO:7726: 1.77
Carilex Medical (ROCO:7726) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Carilex Medical 5-Year Yield-on-Cost % Related Terms
ROCO:7726 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Carilex Medical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carilex Medical 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carilex Medical's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Carilex Medical's 5-Year Yield-on-Cost % falls into.
Carilex Medical 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Carilex Medical is calculated as
Carilex Medical (ROCO:7726) has a 5-Year Yield-on-Cost % of 1.77 as of Aug. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Carilex Medical and its competitors. This is 57% below median its historical median of 4.13. Over the past decade, Carilex Medical's 5-Year Yield-on-Cost % has ranged from 1.39 to 5.15. According to the industry distribution chart, Carilex Medical ranks #183 out of 317 companies in the Medical Devices & Instruments industry, placing it in the top 57.7%.
Is Carilex Medical's 5-Year Yield-on-Cost % too high?
Carilex Medical's current 5-Year Yield-on-Cost % of 1.77 is 57% below median its 10-year median of 4.13. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 5.15. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.29. Carilex Medical's value of 1.77 is 22.7% below this industry median. Based on the distribution chart, Carilex Medical ranks #183 out of 317 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Carilex Medical has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Carilex Medical's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Carilex Medical ranks #183 out of 317 companies for 5-Year Yield-on-Cost %. This places Carilex Medical in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.29. Carilex Medical's value of 1.77 is 22.7% below this benchmark. Historically, Carilex Medical's own 5-Year Yield-on-Cost % has ranged from 1.39 to 5.15 over the past decade. While the company's 10-year median is 4.13 vs. the industry median of 2.29, Carilex Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.29, based on 317 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carilex Medical's current 5-Year Yield-on-Cost % of 1.77 is 22.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Carilex Medical and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carilex Medical's current 5-Year Yield-on-Cost % is 1.77, which is 57% below median its own 10-year median of 4.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carilex Medical stock overvalued right now?
Carilex Medical (ROCO:7726) has a current 5-Year Yield-on-Cost % of 1.77. The current 5-Year Yield-on-Cost % is 1.77, which is 57% below median its 10-year median of 4.13 and 22.7% below the Medical Devices & Instruments industry median of 2.29. Carilex Medical's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Carilex Medical (ROCO:7726), the current 5-Year Yield-on-Cost % is 1.77 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.
33GF Score
Get the complete analysis for ROCO:7726
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7726 has been successfully added to your 
